Clinical trials
22q11 Deletion Syndrome trials in the Netherlands
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
1 trial matches Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2018 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| dr. Laura C. G. de Graaff-Herder | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| 22q11 Deletion Syndrome | 1 |
| Acrocephalosyndactylia | 1 |
| Adrenal Hyperplasia, Congenital | 1 |
| Bardet-Biedl Syndrome | 1 |
| CHARGE Syndrome | 1 |
| De Lange Syndrome | 1 |
| DiGeorge Syndrome | 1 |
| Disorder of Sex Development, 46,XY | 1 |
| Disorders of Sex Development | 1 |
| Jacobsen Distal 11q Deletion Syndrome | 1 |
Trials
Showing 1 to 1 of 1. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.